Drug recall · November 23, 2022
Timolol-Latanoprost recall
Why: Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
- Lots / codes
Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023
- Quantity
- 960 bottles
- Company
- ImprimisRx NJ, Ledgewood, NJ
- Distribution
- Nationwide in the USA
- Initiated
- November 9, 2022 · Voluntary: Firm initiated
- Classified
- November 14, 2022
- Reported
- November 23, 2022
- Ended
- August 23, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.